FLSM
MRUS

Frazier Life Sciences Management’s Merus MRUS Stock Holding History

Frazier Life Sciences Management’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-373,100
Closed -$15.7M – 52
2025
Q1 		$15.7M Hold
373,100
– – 0.72% 27
2024
Q4 		$15.7M Hold
373,100
– – 0.65% 30
2024
Q3 		$18.6M Hold
373,100
– – 0.75% 30
2024
Q2 		$22.1M Sell
373,100
-373,379
-50% -$18.1M 1.03% 25
2024
Q1 		$33.6M Hold
746,479
– – 1.42% 23
2023
Q4 		$20.5M Hold
746,479
– – 1.1% 25
2023
Q3 		$17.6M Hold
746,479
– – 1.17% 20
2023
Q2 		$19.7M Hold
746,479
– – 1.17% 21
2023
Q1 		$13.7M Hold
746,479
– – 0.99% 25
2022
Q4 		$11.5M Hold
746,479
– – 0.72% 27
2022
Q3 		$15M Buy
746,479
+72,500
+11% +$1.73M 1.15% 21
2022
Q2 		$15.3M Buy
673,979
+45,000
+7% +$939K 1.44% 19
2022
Q1 		$16.6M Buy
+628,979
New +$16.9M 1.42% 23

Other funds holding MRUS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Frazier Life Sciences Management's MRUS Position: Q2 2025 in Review

Frazier Life Sciences Management sold out of Merus (MRUS) in Q2 2025, closing a stake of 373,100 shares — an estimated $15.7M sold.

Frazier Life Sciences Management first reported a position in MRUS in Q1 2022 and held it in 13 quarters. The position peaked at $33.6M in Q1 2024. 200 funds tracked by Wall St. Rank hold MRUS as of Q2 2025.

  • Frazier Life Sciences Management reported no remaining Merus position as of Q2 2025 after selling out during the quarter.
  • Frazier Life Sciences Management sold 373,100 Merus shares in Q2 2025, an estimated $15.7M.
  • Frazier Life Sciences Management first reported a position in Merus in Q1 2022 and held it in 13 quarters.
  • Frazier Life Sciences Management's Merus position peaked at $33.6M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Merus as of Q2 2025.

Based on Frazier Life Sciences Management's 13F filing for Q2 2025, filed 14 Aug 2025.